37 related articles for article (PubMed ID: 30345618)
1. Recent metformin adherence and the risk of hypoglycaemia in the year following intensification with a sulfonylurea.
Min JY; Griffin MR; Chipman J; Hackstadt AJ; Greevy RA; Grijalva CG; Hung AM; Roumie CL
Diabet Med; 2019 Apr; 36(4):482-490. PubMed ID: 30378161
[TBL] [Abstract][Full Text] [Related]
2. Effects of Body Mass Index, Glycemic Control, and Hypoglycemic Drugs on Serum Uric Acid Levels in Type 2 Diabetic Patients.
Hussain A; Latiwesh OB; Ali F; Younis MYG; Alammari JA
Cureus; 2018 Aug; 10(8):e3158. PubMed ID: 30349765
[TBL] [Abstract][Full Text] [Related]
3. Optimizing diabetic kidney disease animal models: Insights from a meta-analytic approach.
Li F; Ma Z; Cai Y; Zhou J; Liu R
Animal Model Exp Med; 2023 Oct; 6(5):433-451. PubMed ID: 37723622
[TBL] [Abstract][Full Text] [Related]
4. Impairment of Mitochondrial Respiration in Metabolic Diseases: An Overview.
Avram VF; Merce AP; Hâncu IM; Bătrân AD; Kennedy G; Rosca MG; Muntean DM
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012137
[TBL] [Abstract][Full Text] [Related]
5. Mitochondria in Diabetic Kidney Disease.
Ahmad AA; Draves SO; Rosca M
Cells; 2021 Oct; 10(11):. PubMed ID: 34831168
[TBL] [Abstract][Full Text] [Related]
6. Reno-Protective Effect of GLP-1 Receptor Agonists in Type1 Diabetes: Dual Action on TRPC6 and NADPH Oxidases.
Youssef N; Noureldein M; Njeim R; Ghadieh HE; Harb F; Azar ST; Fares N; Eid AA
Biomedicines; 2021 Sep; 9(10):. PubMed ID: 34680477
[TBL] [Abstract][Full Text] [Related]
7. A review on protective roles and potential mechanisms of metformin in diabetic patients diagnosed with COVID-19.
Kifle ZD; Woldeyohanis AE; Demeke CA
Metabol Open; 2021 Dec; 12():100137. PubMed ID: 34664036
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial Regulation of Diabetic Kidney Disease.
Galvan DL; Mise K; Danesh FR
Front Med (Lausanne); 2021; 8():745279. PubMed ID: 34646847
[TBL] [Abstract][Full Text] [Related]
9. Metformin Use Is Associated with Decreased Mortality in COVID-19 Patients with Diabetes: Evidence from Retrospective Studies and Biological Mechanism.
Poly TN; Islam MM; Li YJ; Lin MC; Hsu MH; Wang YC
J Clin Med; 2021 Aug; 10(16):. PubMed ID: 34441802
[TBL] [Abstract][Full Text] [Related]
10. Metformin attenuates renal tubulointerstitial fibrosis via upgrading autophagy in the early stage of diabetic nephropathy.
Wang F; Sun H; Zuo B; Shi K; Zhang X; Zhang C; Sun D
Sci Rep; 2021 Aug; 11(1):16362. PubMed ID: 34381133
[TBL] [Abstract][Full Text] [Related]
11. Shaping Up Mitochondria in Diabetic Nephropathy.
Mise K; Galvan DL; Danesh FR
Kidney360; 2020 Sep; 1(9):982-992. PubMed ID: 34189465
[TBL] [Abstract][Full Text] [Related]
12. Metformin Protects against Podocyte Injury in Diabetic Kidney Disease.
Lehtonen S
Pharmaceuticals (Basel); 2020 Dec; 13(12):. PubMed ID: 33321755
[TBL] [Abstract][Full Text] [Related]
13. Accelerated Kidney Aging in Diabetes Mellitus.
Guo J; Zheng HJ; Zhang W; Lou W; Xia C; Han XT; Huang WJ; Zhang F; Wang Y; Liu WJ
Oxid Med Cell Longev; 2020; 2020():1234059. PubMed ID: 32774664
[TBL] [Abstract][Full Text] [Related]
14. Significance of Metformin Use in Diabetic Kidney Disease.
Kawanami D; Takashi Y; Tanabe M
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545901
[TBL] [Abstract][Full Text] [Related]
15. Metformin: the updated protective property in kidney disease.
Pan Q; Lu X; Zhao C; Liao S; Chen X; Guo F; Yang C; Liu HF
Aging (Albany NY); 2020 May; 12(9):8742-8759. PubMed ID: 32364526
[TBL] [Abstract][Full Text] [Related]
16. Metformin attenuates renal medullary hypoxia in diabetic nephropathy through inhibition uncoupling protein-2.
Christensen M; Schiffer TA; Gustafsson H; Krag SP; Nørregaard R; Palm F
Diabetes Metab Res Rev; 2019 Feb; 35(2):e3091. PubMed ID: 30345618
[TBL] [Abstract][Full Text] [Related]
17. Acute SGLT inhibition normalizes O2 tension in the renal cortex but causes hypoxia in the renal medulla in anaesthetized control and diabetic rats.
O'Neill J; Fasching A; Pihl L; Patinha D; Franzén S; Palm F
Am J Physiol Renal Physiol; 2015 Aug; 309(3):F227-34. PubMed ID: 26041448
[TBL] [Abstract][Full Text] [Related]
18. Endothelin type A receptor inhibition normalises intrarenal hypoxia in rats used as a model of type 1 diabetes by improving oxygen delivery.
Franzén S; Palm F
Diabetologia; 2015 Oct; 58(10):2435-42. PubMed ID: 26173672
[TBL] [Abstract][Full Text] [Related]
19. Deletion of Uncoupling Protein-2 reduces renal mitochondrial leak respiration, intrarenal hypoxia and proteinuria in a mouse model of type 1 diabetes.
Friederich-Persson M; Persson P; Hansell P; Palm F
Acta Physiol (Oxf); 2018 Aug; 223(4):e13058. PubMed ID: 29480974
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
